168 filings
10-K
2023 FY
IKT
Inhibikase Therapeutics Inc
Annual report
27 Mar 24
4:05pm
8-K
IKT
Inhibikase Therapeutics Inc
7 Feb 24
Inhibikase Therapeutics Announces Preliminary Outcomes of its Pre-NDA
7:59am
424B5
IKT
Inhibikase Therapeutics Inc
1 Feb 24
Prospectus supplement for primary offering
4:49pm
8-K
IKT
Inhibikase Therapeutics Inc
1 Feb 24
Entry into a Material Definitive Agreement
4:09pm
8-K
IKT
Inhibikase Therapeutics Inc
16 Jan 24
Inhibikase Therapeutics Announces Planned Retirement of Chief Financial Officer Joseph Frattaroli
4:31pm
10-Q
2023 Q3
IKT
Inhibikase Therapeutics Inc
Quarterly report
14 Nov 23
4:15pm
8-K
IKT
Inhibikase Therapeutics Inc
20 Sep 23
Inhibikase Therapeutics Issues a Letter to Shareholders and Comments on Recent Trading Activity
11:23am
10-Q
2023 Q2
IKT
Inhibikase Therapeutics Inc
Quarterly report
14 Aug 23
4:07pm
8-K
IKT
Inhibikase Therapeutics Inc
17 Jul 23
Other Events
5:29pm
4
Dennis N Berman
5 Jul 23
Inhibikase Therapeutics / DENNIS N BERMAN ownership change
9:18pm
4
IKT
Inhibikase Therapeutics Inc
5 Jul 23
Inhibikase Therapeutics / Gisele Dion ownership change
9:16pm
4
Paul C Grint
5 Jul 23
Inhibikase Therapeutics / PAUL C GRINT ownership change
9:12pm
4
Freeman Roy Lester
5 Jul 23
Inhibikase Therapeutics / Roy Lester Freeman ownership change
9:11pm
8-K
IKT
Inhibikase Therapeutics Inc
29 Jun 23
Inhibikase Therapeutics Announces a 1-for-6 Reverse Stock Split
12:15pm
8-K
IKT
Inhibikase Therapeutics Inc
28 Jun 23
Submission of Matters to a Vote of Security Holders
7:08am
10-Q
2023 Q1
IKT
Inhibikase Therapeutics Inc
Quarterly report
15 May 23
8:01am
DEFA14A
IKT
Inhibikase Therapeutics Inc
12 May 23
Additional proxy soliciting materials
4:16pm
ARS
2022 FY
IKT
Inhibikase Therapeutics Inc
5 May 23
Annual report to shareholders
4:35pm
DEF 14A
IKT
Inhibikase Therapeutics Inc
Definitive proxy
5 May 23
4:31pm